Texas A&M Football Recruiting

Around the SEC: Early Signing Period News & Notes

The Early Signing Period has come and gone as a number of the nation's top prospects have signed on the dotted line. It is time to take a look at the latest happenings in the SEC footprint on the recruiting front.
By Jason Howell
December 4, 2025
4.9k Views
Discuss
Story Poster
Photo by Ray Carlin-USA TODAY Sports

Signing Day has come and gone, and it brought with it its share of drama and theatre. Now it is time to take a look around at the latest news, notes and headlines from the conference.

To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Around the SEC Early Signing Period Early Signing Period 2025 Dia Bell Lamar Brown Deuce Geralds Brysten Martinez Davian Groce KJ Ford Jared Curtis Landon Barnes Darius Gray
Show All
Landon Duckworth Legend Bey Justice Fitzpatrick Richard Anderson Jake Kreul Xavier Griffin Ekene Ogboko Javari Barnett Tristen Keys Dylan Berymon Anthony Kennedy Brandon Arrington Jorden Edmonds Faizon Brandon Jordan Carter Ezavier Crowell Jerquaden Guilford Danny Beale Kaiden Prothro JJ Finch Jakore Smith Jaquez Wilkes TJ Hodges Carsyn Baker Bralan Womack Salesi Moa Richard Wesley Carter Gooden Vodney Cleveland Jase Mathews Tony Forney Matt Ponatoski Brian Williams Jr James Johnson Johnnie Jones Corey Wells Jett Goldsberry Micah Nickerson Owen Cabell DeShawn Spencer Rhys Brush Mykall Lundy-Foster Football Recruiting 2026
SPONSORED BY
Rio Agave
More Football Recruiting
See All →
Lunch with Liucci: Billy Liucci joins TexAgs Live (Monday, April 27)
By Billy Liucci
Texas A&M Offer Recap 4/20 - 4/26
By Jason Howell
In-Home Vist: Brown's addition elevates A&M's 2027 momentum
By TexAgs Recruiting
Kingwood OL coach Chris Bence talks Kennedy Brown
By Ryan Brauninger
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.